<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.2" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>RBlog &#187; 2007 &#187; February</title>
	<link>http://www.reportbuyer.com/blog</link>
	<description>Sharing intelligence</description>
	<pubDate>Thu, 20 Nov 2008 14:57:29 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2</generator>
	<language>en</language>
			<item>
		<title>Middle East pharma markets could be good growth opportunity</title>
		<link>http://www.reportbuyer.com/blog/middle-east-pharma-markets-could-be-good-growth-opportunity/</link>
		<comments>http://www.reportbuyer.com/blog/middle-east-pharma-markets-could-be-good-growth-opportunity/#comments</comments>
		<pubDate>Sun, 11 Feb 2007 16:05:47 +0000</pubDate>
		<dc:creator>Edwin Bailey</dc:creator>
		
		<category><![CDATA[Pharma &amp; Healthcare]]></category>
<category>king fahd medical city</category><category>Pharma &amp;amp; Healthcare</category><category>pharmaceutical industry</category><category>saudi arabia</category><category>united arab emirates</category>
		<guid isPermaLink="false">http://www.reportbuyer.com/blog/middle-east-pharma-markets-could-be-good-growth-opportunity/</guid>
		<description><![CDATA[The pharmaceutical industry is under constant cost-containment pressures in the US, European and Japanese markets, and as it increases its efforts to expand into emerging markets, the MiddleEastern market – worth an estimated $8bn – could prove a strong growth opportunity for those who appreciate its internal dynamics and unique features

Although the Middle East is [...]]]></description>
		<wfw:commentRss>http://www.reportbuyer.com/blog/middle-east-pharma-markets-could-be-good-growth-opportunity/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
